Stock 3737 ZHONGZHI PHARMACEUTICAL HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Zhongzhi Pharmaceutical Holdings Limited Stock

Equities

3737

KYG989611085

Pharmaceuticals

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:20 2024-04-26 am EDT 		5-day change 1st Jan Change
1.22 HKD 0.00% Intraday chart for Zhongzhi Pharmaceutical Holdings Limited +1.67% -14.08%
Mar. 25 Zhongzhi Pharmaceutical's Attributable Jumps in 2023 MT
Mar. 22 Zhongzhi Pharmaceutical Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 13 June 2024 CI

Financials

Sales 2022 1.83B 252M 1.97B Sales 2023 2.05B 283M 2.21B Capitalization 1.11B 154M 1.2B
Net income 2022 106M 14.63M 115M Net income 2023 163M 22.5M 176M EV / Sales 2022 0.33 x
Net cash position 2022 225M 31.03M 243M Net cash position 2023 17.45M 2.41M 18.85M EV / Sales 2023 0.54 x
P/E ratio 2022
7.66 x
P/E ratio 2023
6.79 x
Employees 2,643
Yield 2022
5.51%
Yield 2023
6.33%
Free-Float 24.24%
More Fundamentals * Assessed data

Chart Zhongzhi Pharmaceutical Holdings Limited

Dynamic Chart

Latest news about Zhongzhi Pharmaceutical Holdings Limited

Zhongzhi Pharmaceutical's Attributable Jumps in 2023 MT
Zhongzhi Pharmaceutical Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 13 June 2024 CI
Zhongzhi Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Zhongzhi Pharmaceutical Expects Over 50% Surge in 2023 Profit MT
Zhongzhi Pharmaceutical Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023 CI
Zhongzhi Pharmaceutical Holdings Limited Approves Interim Dividend CI
Zhongzhi Pharmaceutical’s Profit Up 75% in H1 MT
Zhongzhi Pharmaceutical Holdings Limited Proposes Interim Dividend for the Six Months Ended 30 June 2023, Payable on 2 November 2023 CI
Zhongzhi Pharmaceutical Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Zhongzhi Pharmaceutical Expects 70% Increase in H1 Profit; Shares Jump 7% MT
Zhongzhi Pharmaceutical Holdings Limited Provides Earnings Guidance for the Six Months Ended June 30, 2023 CI
Zhongzhi Pharmaceutical Unit Chooses Builder for New Factory MT
Zhongshan Hengsheng Enters into the Construction Contract with Shenzhen Xinmei CI
Zhongzhi Pharmaceutical Holdings Limited Approves the Declaration and Payment of Special Dividend CI
Zhongzhi Pharmaceutical Holdings Limited Approves the Declaration and Payment of Final Dividend CI
More news

Press releases Zhongzhi Pharmaceutical Holdings Limited

Zhongzhi Pharmaceutical : ANNUAL GENERAL MEETING FOR THE YEAR ENDED 31 DECEMBER 2020 FORM OF PROXY PU
Zhongzhi Pharmaceutical : (1) GENERAL MANDATES TO REPURCHASE AND ISSUE SHARES (2) RE-ELECTION OF DIRECTORS AND (3) NOTICE OF ANNUAL GENERAL MEETING PU
Zhongzhi Pharmaceutical : SUPPLEMENTAL ANNOUNCEMENT DISCLOSEABLE TRANSACTION CONSTRUCTION CONTRACTS PU
Zhongzhi Pharmaceutical : DISCLOSEABLE TRANSACTION CONSTRUCTION CONTRACTS PU
Zhongzhi Pharmaceutical : CHANGE OF CHIEF EXECUTIVE AND CHIEF FINANCIAL OFFICER PU
More press releases

Quotes and Performance

1 week+1.67%
Current month+2.52%
1 month+2.52%
3 months-1.61%
6 months-3.17%
Current year-14.08%
More quotes

Highs and lows

1 week
1.20
Extreme 1.2
1.25
1 month
1.12
Extreme 1.12
1.26
Current year
1.12
Extreme 1.12
1.46
1 year
0.92
Extreme 0.92
1.56
3 years
0.70
Extreme 0.7
1.66
5 years
0.70
Extreme 0.7
1.99
10 years
0.70
Extreme 0.7
2.80
More quotes

Managers and Directors - Zhongzhi Pharmaceutical Holdings Limited

Managers TitleAgeSince
Ying Feng Lai CEO
 Chief Executive Officer 32 14-03-31
Zhi Tian Lai FOU
 Founder 57 14-09-11
Ying Sheng Lai DFI
 Director of Finance/CFO 31 18-09-30
Members of the board TitleAgeSince
Kwun Wan Ng BRD
 Director/Board Member 61 15-06-07
Zhi Tian Lai FOU
 Founder 57 14-09-11
Li Xia Jiang BRD
 Director/Board Member 60 09-02-23
More insiders

Quotes

Date Price Change Volume
24-04-26 1.22 0.00% 0
24-04-25 1.22 0.00% 0
24-04-24 1.22 0.00% 0
24-04-23 1.22 0.00% 0
24-04-22 1.22 +1.67% 26,000

Delayed Quote Hong Kong S.E., April 26, 2024 at 04:08 am EDT

More quotes

Company Profile

Zhongzhi Pharmaceutical Holdings Ltd is a China-based investment holding company. The Company is principally engaged in the research and development, manufacturing and sales of Chinese patent medicines and decoction pieces (consisting of traditional decoction pieces and modern decoction pieces). The Company operates through three segments: pharmaceutical manufacturing segment, operation of chain pharmacies in Zhongshan, Guangdong Province and operation of on-line pharmacies. The Company’s brands include Zeus, Liumian and Caojinghua. The Company mainly conducts its businesses in the domestic market.
Sector
Pharmaceuticals
Calendar
2024-08-21 - Q2 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

1st Jan change Capi.
ZHONGZHI PHARMACEUTICAL HOLDINGS LIMITED Stock Zhongzhi Pharmaceutical Holdings Limited
-14.08% 135M
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+20.44% 21.89B
SANDOZ GROUP AG Stock Sandoz Group AG
+13.64% 14.45B
CIPLA LIMITED Stock Cipla Limited
+13.07% 13.63B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+37.46% 11.49B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.59% 6.85B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+6.35% 5.06B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. Stock Shenzhen Salubris Pharmaceuticals Co., Ltd.
-5.36% 4.66B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 3737 Stock